156 related articles for article (PubMed ID: 15922869)
1. Laminin gamma2-chain fragment circulating level increases in patients with metastatic pancreatic ductal cell adenocarcinomas.
Katayama M; Funakoshi A; Sumii T; Sanzen N; Sekiguchi K
Cancer Lett; 2005 Jul; 225(1):167-76. PubMed ID: 15922869
[TBL] [Abstract][Full Text] [Related]
2. Laminin gamma2-chain fragment in the circulation: a prognostic indicator of epithelial tumor invasion.
Katayama M; Sanzen N; Funakoshi A; Sekiguchi K
Cancer Res; 2003 Jan; 63(1):222-9. PubMed ID: 12517801
[TBL] [Abstract][Full Text] [Related]
3. Expression of laminin-5-gamma-2 chain in intraductal papillary-mucinous and invasive ductal tumors of the pancreas.
Fukushima N; Sakamoto M; Hirohashi S
Mod Pathol; 2001 May; 14(5):404-9. PubMed ID: 11353049
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic expression of laminin gamma2 chain correlates with postoperative hepatic metastasis and poor prognosis in patients with pancreatic ductal adenocarcinoma.
Takahashi S; Hasebe T; Oda T; Sasaki S; Kinoshita T; Konishi M; Ochiai T; Ochiai A
Cancer; 2002 Mar; 94(6):1894-901. PubMed ID: 11920553
[TBL] [Abstract][Full Text] [Related]
5. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
[TBL] [Abstract][Full Text] [Related]
6. Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: a clinicopathologic comparison with a common type of invasive ductal carcinoma.
Shimada K; Sakamoto Y; Sano T; Kosuge T; Hiraoka N
Pancreas; 2006 Apr; 32(3):281-7. PubMed ID: 16628084
[TBL] [Abstract][Full Text] [Related]
7. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
Adsay NV; Basturk O; Cheng JD; Andea AA
Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
[TBL] [Abstract][Full Text] [Related]
8. Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.
Yamaguchi H; Shimizu M; Ban S; Koyama I; Hatori T; Fujita I; Yamamoto M; Kawamura S; Kobayashi M; Ishida K; Morikawa T; Motoi F; Unno M; Kanno A; Satoh K; Shimosegawa T; Orikasa H; Watanabe T; Nishimura K; Ebihara Y; Koike N; Furukawa T
Am J Surg Pathol; 2009 Aug; 33(8):1164-72. PubMed ID: 19440145
[TBL] [Abstract][Full Text] [Related]
9. Invasive ductal adenocarcinoma of the pancreas may originate from the larger pancreatic duct: a study of 13 tumors less than 2 cm in diameter.
Suda K; Nobukawa B; Yamasaki S; Abe K; Matsukuma S; Suzuki F
J Hepatobiliary Pancreat Surg; 2007; 14(3):283-8. PubMed ID: 17520204
[TBL] [Abstract][Full Text] [Related]
10. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakashima A; Sueda T
J Surg Oncol; 2009 Jul; 100(1):13-8. PubMed ID: 19384908
[TBL] [Abstract][Full Text] [Related]
11. CEACAM1, a novel serum biomarker for pancreatic cancer.
Simeone DM; Ji B; Banerjee M; Arumugam T; Li D; Anderson MA; Bamberger AM; Greenson J; Brand RE; Ramachandran V; Logsdon CD
Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843
[TBL] [Abstract][Full Text] [Related]
12. Expression of the laminin gamma 2 chain in pancreatic adenocarcinoma.
Soini Y; Määttä M; Salo S; Tryggvason K; Autio-Harmainen H
J Pathol; 1996 Nov; 180(3):290-4. PubMed ID: 8958807
[TBL] [Abstract][Full Text] [Related]
13. Podocalyxin-like protein 1 expression is useful to differentiate pancreatic ductal adenocarcinomas from adenocarcinomas of the biliary and gastrointestinal tracts.
Ney JT; Zhou H; Sipos B; Büttner R; Chen X; Klöppel G; Gütgemann I
Hum Pathol; 2007 Feb; 38(2):359-64. PubMed ID: 17137615
[TBL] [Abstract][Full Text] [Related]
14. Neovascularization in pancreatic ductal adenocarcinoma: Microvessel count analysis, comparison with non-cancerous regions and other types of carcinomas.
Ueda T; Oda T; Kinoshita T; Konishi M; Nakahashi C; Takahashi S; Hasebe T; Fukao K; Ochiai A
Oncol Rep; 2002; 9(2):239-45. PubMed ID: 11836587
[TBL] [Abstract][Full Text] [Related]
15. Regulation of biological activity of laminin-5 by proteolytic processing of gamma2 chain.
Ogawa T; Tsubota Y; Maeda M; Kariya Y; Miyazaki K
J Cell Biochem; 2004 Jul; 92(4):701-14. PubMed ID: 15211568
[TBL] [Abstract][Full Text] [Related]
16. Incidence of additional primary cancers in patients with invasive intraductal papillary mucinous neoplasms and sporadic pancreatic adenocarcinomas.
Riall TS; Stager VM; Nealon WH; Townsend CM; Kuo YF; Goodwin JS; Freeman JL
J Am Coll Surg; 2007 May; 204(5):803-13; discussion 813-4. PubMed ID: 17481488
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of frozen section analysis during resection of intraductal papillary mucinous neoplasm: should a positive pancreatic margin for adenoma or borderline lesion be resected additionally?
Nara S; Shimada K; Sakamoto Y; Esaki M; Kosuge T; Hiraoka N
J Am Coll Surg; 2009 Nov; 209(5):614-21. PubMed ID: 19854402
[TBL] [Abstract][Full Text] [Related]
18. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
[TBL] [Abstract][Full Text] [Related]
19. [Assay of the laminin P1 using a radioimmunologic technic: applications in oncology].
Larbre H; Loemba L; Deltour G
Bull Cancer; 1989; 76(9):947-53. PubMed ID: 2620128
[TBL] [Abstract][Full Text] [Related]
20. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.
Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
